Trials / Completed
CompletedNCT05044533
A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)
Evaluating QUAlity of Life of AF Patients Following a Bleed (EQUAL-AF)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to identify participants with both minor and major bleeds as a result of anticoagulant treatment for AF and evaluating their QoL through both primary and secondary care settings.
Conditions
Timeline
- Start date
- 2021-05-31
- Primary completion
- 2022-03-09
- Completion
- 2022-03-09
- First posted
- 2021-09-14
- Last updated
- 2023-06-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05044533. Inclusion in this directory is not an endorsement.